GADICKE ANSBERT

CIK 000113465517 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001134655

Recent Transactions

50 trades

Disposition to Issuer
Radius Health, Inc.
Common Stock
2011-05-17$0.01/sh−5,000,000→ 0 total
Award
Radius Health, Inc.
Series A-2 Convertible Preferred Stock
2011-05-17+402,115→ 402,115 total
Award
Radius Health, Inc.
Series A-3 Convertible Preferred Stock
2011-05-17+53,331→ 53,331 total
Award
Radius Health, Inc.
Series A-2 Convertible Preferred Stock
2011-05-17+402,115→ 402,115 total
Award
Radius Health, Inc.
Series A-3 Convertible Preferred Stock
2011-05-17+53,331→ 53,331 total
Disposition to Issuer
Radius Health, Inc.
Common Stock
2011-05-17$0.01/sh−5,000,000→ 0 total
Award
Radius Health, Inc.
Series A-1 Convertible Preferred Stock
2011-05-17+200,909→ 200,909 total
Award
Radius Health, Inc.
Series A-1 Convertible Preferred Stock
2011-05-17+200,909→ 200,909 total
Purchase
ReShape Weightloss Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.13/sh+704,607→ 704,607 total
Purchase
ARYx Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.01/sh+500,000→ 500,000 total
Purchase
ReShape Weightloss Inc.
Series A Non-Voting Convertible Preferred Stock
2010-09-30$1.72/sh+704,607→ 704,607 total
Purchase
ReShape Weightloss Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.13/sh+704,607→ 704,607 total
Purchase
ARYx Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.01/sh+500,000→ 500,000 total
Purchase
ReShape Weightloss Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.13/sh+704,607→ 704,607 total
Purchase
ARYx Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.01/sh+500,000→ 500,000 total
Purchase
ReShape Weightloss Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.13/sh+704,607→ 704,607 total
Purchase
ARYx Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.01/sh+500,000→ 500,000 total
Purchase
ReShape Weightloss Inc.
Series A Non-Voting Convertible Preferred Stock
2010-09-30$1.72/sh+704,607→ 704,607 total
Purchase
ARYx Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.01/sh+500,000→ 500,000 total
Purchase
ReShape Weightloss Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.13/sh+704,607→ 704,607 total
Purchase
ReShape Weightloss Inc.
Series A Non-Voting Convertible Preferred Stock
2010-09-30$1.72/sh+704,607→ 704,607 total
Purchase
ARYx Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.01/sh+500,000→ 500,000 total
Purchase
ReShape Weightloss Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.13/sh+704,607→ 704,607 total
Purchase
ReShape Weightloss Inc.
Series A Non-Voting Convertible Preferred Stock
2010-09-30$1.72/sh+704,607→ 704,607 total
Purchase
ReShape Weightloss Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.13/sh+704,607→ 704,607 total
Purchase
ReShape Weightloss Inc.
Series A Non-Voting Convertible Preferred Stock
2010-09-30$1.72/sh+704,607→ 704,607 total
Purchase
ReShape Weightloss Inc.
Series A Non-Voting Convertible Preferred Stock
2010-09-30$1.72/sh+704,607→ 704,607 total
Purchase
ReShape Weightloss Inc.
Series A Non-Voting Convertible Preferred Stock
2010-09-30$1.72/sh+704,607→ 704,607 total
Purchase
ARYx Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.01/sh+500,000→ 500,000 total
Other
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2010-01-01−7,913,653→ 14,633,961 total
Other
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2010-01-01−7,913,653→ 14,633,961 total
Other
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2010-01-01−7,913,653→ 14,633,961 total
Other
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2010-01-01−7,913,653→ 14,633,961 total
Other
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2010-01-01−7,913,653→ 14,633,961 total
Other
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2010-01-01−7,913,653→ 14,633,961 total
Other
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2010-01-01−7,913,653→ 14,633,961 total
Other
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2010-01-01−7,913,653→ 14,633,961 total
Disposition from Tender
MEMORY PHARMACEUTICALS CORP
Common Stock
2009-01-01$0.61/sh−14,138,993→ 0 total
Disposition from Tender
MEMORY PHARMACEUTICALS CORP
Common Stock
2009-01-01$0.61/sh−14,138,993→ 0 total
Disposition from Tender
MEMORY PHARMACEUTICALS CORP
Common Stock
2009-01-01$0.61/sh−14,138,993→ 0 total
Disposition from Tender
MEMORY PHARMACEUTICALS CORP
Common Stock
2009-01-01$0.61/sh−14,138,993→ 0 total
Disposition from Tender
MEMORY PHARMACEUTICALS CORP
Common Stock
2009-01-01$0.61/sh−14,138,993→ 0 total
Disposition from Tender
MEMORY PHARMACEUTICALS CORP
Common Stock
2009-01-01$0.61/sh−14,138,993→ 0 total
Disposition from Tender
MEMORY PHARMACEUTICALS CORP
Common Stock
2009-01-01$0.61/sh−14,138,993→ 0 total
Disposition from Tender
MEMORY PHARMACEUTICALS CORP
Common Stock
2009-01-01$0.61/sh−14,138,993→ 0 total
Disposition from Tender
MEMORY PHARMACEUTICALS CORP
Common Stock
2009-01-01$0.61/sh−14,138,993→ 0 total
Sale
Pharmasset Inc
Common Stock
2008-06-19$19.90/sh−153,700→ 2,120,431 total
Sale
Pharmasset Inc
Common Stock
2008-06-19$20.00/sh−1,400→ 2,118,331 total
Sale
Pharmasset Inc
Common Stock
2008-06-19$19.91/sh−500→ 2,119,931 total
Sale
Pharmasset Inc
Common Stock
2008-06-19$19.94/sh−100→ 2,119,731 total

Companies

Recent Filings

4
GADICKE ANSBERT
Dec 4, 2025

Address

C/O MPM ASSET MANAGEMENT 200 CLARENDON ST., 54TH FLOOR

BOSTON, MA, 02116

View on SEC.gov